Bactolac Pharmaceutical, Inc.

Bactolac Pharmaceutical is a leading nutritional supplement manufacturer based in New York. Founded in 1995, the company boasts a team of experienced scientists and pharmacists dedicated to providing high-quality vitamins and supplements at competitive prices. Operating from a 350,000 square foot cGMP certified facility, Bactolac offers a full-service approach encompassing manufacturing, testing, packaging, labeling, and distribution, all in adherence to FDA requirements. The company's product range includes nutraceutical capsules, sublingual, soft gels, liquids, chewables, tablets, and powders available for private label manufacturing. Moreover, Bactolac extends turnkey services for creating, producing, and marketing nutritional supplements, catering to businesses of various sizes. The company emphasizes its commitment to enabling customers to achieve their goals by delivering top-quality products at affordable prices. Bactolac also encourages potential partners to visit their facilities, offering tours and meetings to showcase their capabilities. With a focus on the manufacturing and nutrition industries, Bactolac Pharmaceutical represents a promising opportunity for venture capital investment. Its established presence and comprehensive services position the company as an attractive prospect for investors seeking exposure to the thriving health and wellness supplementation market. For more information, interested parties can visit Bactolac's website or contact them directly.